Stocks making the biggest moves midday: Biogen, McDonald's, UPS and more

— The airline's stock jumped nearly 5% on the back of better-than-expected earnings. JetBlue posted adjusted earnings per share of 59 cents. Analysts polled by Refinitiv expected a profit of 51 cents a share. "We are just beginning to see the benefits of our revenue, cost, fleet and capital allocation efforts," CEO Robin Hayes said in a statement.— Shares of UPS fell about 2.5% after the carrier reported quarterly revenues of $18.32 billion, just missing consensus expectations.

— The Milwaukee-based motorcycle manufacturer rallied more than 6% after it surprised investors Tuesday with earnings results well ahead of expectations. Harley-Davidson reported earnings per share four cents ahead of forecasts, driven by a smaller-than-expected U.S. sales decline and a 2.7% climb in international revenues.— Shares of toy company Hasbro tanked 13% after falling short of expectations for its third-quarter earnings. Hasbro earned $1.

McDonalds is about to get 28 billion in subsidies (welfare) for it's products. Damn right it's shares should be more valuable.

I got news for you. UPS is soooooooo slow this year. Volume is way down. They had already told their seasonal drivers to take several days off due to low volume which has never happened. They are not going to do good this year. Trailers are moving with 40% loads vs 100% last yr

Our mission at is to build the social news network that ends fake news. Follow us Overlooked_Inc

BMS

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Stocks making the biggest moves premarket: Biogen, Under Armour, P&G, Hasbro & moreThese are the stocks posting the largest moves before the bell.
Source: CNBC - 🏆 12. / 72 Read more »

Biogen resurrects Alzheimer's drug; shares jump 35%Biogen Inc revealed surprise plans to seek U.S. regulatory approval for its Alzh...
Source: Reuters - 🏆 2. / 97 Read more »

Biogen, in Reversal, Will Seek FDA OK for Alzheimer’s Drug After Further AnalysisBiogen said it plans to pursue regulatory approval for aducanumab, an investigational treatment for early Alzheimer’s disease, after pulling the plug on phase 3 studies of the drug earlier this year. We shudder to think of this drug's monthly price tag should it be approved for the market and who is going to pay for it. no medical innovations out of China? didn't think so. Trump2020
Source: WSJ - 🏆 98. / 63 Read more »

Biogen soars 40% on Alzheimer's drug revival: 'It would be the biggest drug ever,' Cramer saysDrug maker Biogen announced it is seeking regulatory approval for its Alzheimer's drug, months after it stopped testing the treatment. OMG But does it work for patients? May be doesn’t excite me
Source: CNBC - 🏆 12. / 72 Read more »

Stocks making the biggest moves midday: Coty, Boeing, HPE, Apple, IBM & moreThese are the stocks posting the largest moves midday Monday.
Source: CNBC - 🏆 12. / 72 Read more »

European stocks seen cautiously higher as Brexit uncertainty returnsEuropean stocks were seen cautiously higher Monday morning as traders wait to discover whether the U.K.'s departure from the European Union will be delayed once again. The Uk just needs to stay in the EU The UK should and is going to stay part of the European union.. The UK needs the union just as much and Together we all can be STRONGER ! 🤘❤🥂🍾
Source: CNBC - 🏆 12. / 72 Read more »